General Biological
PrivateLast Round
Seed
Dec 1, 2024
Total Funding Raised
$13.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
General Biological is an industrial biotechnology company developing a biomanufacturing platform to produce specialty chemicals and materials from renewable feedstocks.
Sector
Energy & Sustainability
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
General Biological Comparables
Compare General Biological with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capra Biosciences | 82% | |
| Biosphere | 80% | |
| Visolis | 79% |
General Biological Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2024 | ||||
| Grant | Mar 31, 2023 |
General Biological Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yale Center for Business and the Environment | Grant |
| BoxGroup | Seed |
| Abstract Ventures | Seed |
| Lowercarbon Capital | Seed |
| CIV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 26, 173% of headcount.
Recent news
Latest coverage and updates
- expands_facilitiesSep 15, 2026
General Biological Corporation expands facilities to Berwick, Pennsylvania, United States, Northern America, Americas.
General Biological Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about General Biological's valuation, stock price, and market status.
Is General Biological a public or private company?
General Biological is a private company.
What is the current stock price of General Biological?
General Biological is a private company with no public stock price. No recent secondary market data is available.
How much is General Biological worth (valuation)?
Valuation information for General Biological is not publicly available.
Can I buy General Biological stock?
General Biological shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was General Biological's last funding round?
General Biological's most recent funding round was Seed on December 1, 2024.
Who are the main investors in General Biological?
Key investors in General Biological include Yale Center for Business and the Environment, BoxGroup, Abstract Ventures, Lowercarbon Capital, CIV.
Will General Biological IPO soon?
No public IPO plans have been announced for General Biological.
How can I track General Biological secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor General Biological's secondary market activity and sign up for updates.